股本结构
单位：万股
| 公告日期 | 2026-03-10 | 2026-03-10 | 2025-11-17 | 2025-11-17 | 2025-08-05 | 2025-08-05 |
|---|---|---|---|---|---|---|
| 证券总股本 | 4797.38 | 4665.70 | 4813.59 | 4658.33 | 4741.74 | 4503.82 |
| 普通股本 | 4797.38 | 4665.70 | 4813.59 | 4658.33 | 4741.74 | 4503.82 |
| 优先股 | 未披露 | 140.00 | 未披露 | 140.00 | 未披露 | 140.00 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-03-09 | 2025-12-31 | 2025-11-14 | 2025-09-30 | 2025-08-04 | 2025-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-03-10 | 4797.38 | 未披露 | 定期报告 | 2026-03-09 |
| 2026-03-10 | 4665.70 | 140.00 |
更多>>
From December 31, 2024 to December 31, 2025
Stock compensation expense
Stock issued for debt conversion
Stock issued for asset acquisition
Exercise of stock options
Exercise of warrants
Sale of common stock under ATM, net
Cashless exercise of stock options
Cashless exercise of warrants
|
2025-12-31 |
| 2025-11-17 | 4813.59 | 未披露 | 定期报告 | 2025-11-14 |
| 2025-11-17 | 4658.33 | 140.00 |
更多>>
From June 30, 2025 to September 30, 2025
Stock compensation expense
Cashless exercise of stock options
Exercise of stock options
Exercise of warrants
Sale of common stock under ATM, net
|
2025-09-30 |
| 2025-08-05 | 4741.74 | 未披露 | 定期报告 | 2025-08-04 |
| 2025-08-05 | 4503.82 | 140.00 |
更多>>
From March 31, 2025 to June 30, 2025
Stock compensation expense
Cashless exercise of stock options
Cashless exercise of warrants
Stock issued for debt conversion
Stock issued for asset acquisition
|
2025-06-30 |
| 2025-05-06 | 4544.76 | 未披露 | 定期报告 | 2025-05-05 |
| 2025-04-28 | 4396.85 | 未披露 | 定期报告 | 2025-04-23 |
| 2025-05-06 | 4352.97 | 140.00 |
更多>>
From January 1, 2025 to March 31, 2025
Cashless exercise of options
Stock compensation expense
|
2025-03-31 |
| 2025-03-11 | 4458.37 | 未披露 | 定期报告 | 2025-03-07 |
| 2025-03-11 | 4219.09 | 140.00 |
更多>>
From December 31, 2023 to December 31, 2024
Stock compensation expense
Stock issued for noncontingent consideration payment
Exercise of stock options
Cashless exercise of warrants
Cashless exercise of stock options
|
2024-12-31 |
| 2024-11-07 | 4331.21 | 未披露 | 定期报告 | 2024-11-06 |
| 2024-11-07 | 4180.65 | 140.00 |
更多>>
From June 30, 2024 to September 30, 2024
Stock compensation expense
|
2024-09-30 |
| 2024-08-07 | 4306.89 | 未披露 | 定期报告 | 2024-08-06 |
| 2024-07-05 | 4175.65 | 未披露 | 定期报告 | 2024-07-03 |
| 2024-08-07 | 4165.65 | 140.00 |
更多>>
From March 31, 2024 to June 30, 2024
Stock compensation expense
Exercise of stock options
Cashless exercise of stock options
Cashless exercise of warrants
|
2024-06-30 |
| 2024-05-31 | 4156.15 | 未披露 | 定期报告 | 2024-05-23 |
| 2024-05-08 | 4229.00 | 未披露 | 定期报告 | 2024-05-07 |
| 2024-04-29 | 4088.83 | 未披露 | 定期报告 | 2024-04-24 |
| 2024-05-08 | 4062.86 | 140.00 |
更多>>
From January 1, 2024 to March 31, 2024
Stock compensation expense
Cashless exercise of options
Stock issued for noncontingent consideration payment
Exercise of stock options
Cashless exercise of warrants
|
2024-03-31 |
| 2024-03-11 | 4036.60 | 未披露 | 定期报告 | 2024-03-08 |
| 2024-03-11 | 3825.56 | 140.00 |
更多>>
From December 31,2022 to December 31,2023
Stock compensation expense
Cashless exercise of stock options
Cashless exercise of warrants
Exercise of stock options
Stock issued for noncontingent consideration payments
Stock issued for legal settlement
Sale of common stock under ATM, net
Stock issued for debt conversion
Common stock issued to Medifast
Series B Preferred Stock conversion
|
2023-12-31 |
| 2023-11-08 | 3797.88 | 未披露 | 定期报告 | 2023-11-07 |
| 2023-11-08 | 3465.62 | 140.00 |
更多>>
From June 30, 2023 to September 30, 2023
Sale of common stock under ATM, net
Series B Preferred Stock conversion
Cashless exercise of stock options
Stock compensation expense
Stock issued for noncontingent consideration payment
Stock issued for legal settlement
|
2023-09-30 |
| 2023-08-09 | 3603.27 | 未披露 | 定期报告 | 2023-08-08 |
| 2023-05-12 | 3241.18 | 未披露 | 定期报告 | 2023-05-11 |
| 2023-04-28 | 3395.12 | 未披露 | 定期报告 | 2023-04-24 |
| 2023-05-12 | 3193.70 | 140.35 |
更多>>
From January 1, 2023 to March 31, 2023
Stock compensation expense
Stock issued for noncontingent consideration payment
|
2023-03-31 |
| 2023-03-22 | 3188.70 | 未披露 | 定期报告 | 2023-03-21 |
| 2023-03-22 | 3144.97 | 140.35 |
更多>>
From December 31, 2021 to December 31, 2022
Stock compensation expense
Exercise of stock options
Exercise of warrants
Cashless exercise of stock options
Stock issued for legal settlement
|
2022-12-31 |
| 2022-11-10 | 3144.97 | 未披露 | 定期报告 | 2022-11-09 |
| 2022-11-10 | 3135.47 | 140.35 |
更多>>
From June 30, 2022 to September 30, 2022
Stock compensation expense
Stock issued for legal settlement
Cashless exercise of stock options
|
2022-09-30 |
| 2022-08-11 | 3095.06 | 未披露 | 定期报告 | 2022-08-10 |
| 2022-08-11 | 3088.68 | 140.35 |
更多>>
From March 31, 2022 to June 30, 2022
Exercise of stock options
|
2022-06-30 |
| 2022-08-17 | 3079.64 | 140.00 | 定期报告 | 2022-06-29 |
| 2022-05-13 | 3079.64 | 未披露 | 定期报告 | 2022-05-12 |
| 2022-04-29 | 3089.95 | 0.35 | 定期报告 | 2022-04-25 |
| 2022-05-13 | 3079.64 | 140.35 |
更多>>
From January 1, 2022 to March 31, 2022
Stock compensation
Cashless exercise of stock options
Exercise of warrants
|
2022-03-31 |
| 2022-08-17 | 3084.64 | 140.00 | 定期报告 | 2022-03-24 |
| 2022-03-07 | 3083.33 | 未披露 | 定期报告 | 2022-03-04 |
| 2022-03-07 | 3060.14 | 140.35 |
更多>>
From December 31, 2020 to December 31, 2021
Stock issued for services
Exercise of stock options
Exercise of warrants
Cashless exercise of stock options
Warrants issued for debt instruments
Sale of common stock in private placement, net
Sale of common stock under ATM, net
Sale of Series A Preferred Stock
Sale of common stock
|
2021-12-31 |
| 2021-11-10 | 3059.33 | 未披露 | 定期报告 | 2021-11-09 |
| 2021-10-04 | 3009.33 | 未披露 |
更多>>
1.Common stock offered 3,333,334 shares.
2.The number of shares of common stock outstanding before and after this offering is based on 26,759,935 shares of common stock outstanding as of September 24, 2021.
|
2021-10-04 |
| 2021-11-10 | 2675.99 | 0.35 |
更多>>
From June 30, 2021 to September 30, 2021
Stock issued for services
Exercise of stock options
Exercise of warrants
Sale of common stock under ATM
|
2021-09-30 |
| 2021-09-28 | 2675.99 | 未披露 | 定期报告 | 2021-09-24 |
| 2021-08-13 | 2656.28 | 未披露 | 定期报告 | 2021-08-12 |
| 2021-07-23 | 2666.58 | 未披露 | 定期报告 | 2021-07-12 |
| 2021-08-13 | 2653.28 | 0.35 |
更多>>
From March 31, 2021 to June 30, 2021
Stock issued for services
Exercise of stock options
Cashless exercise of stock options
Exercise of warrants
|
2021-06-30 |
| 2021-06-08 | 2657.19 | 0.35 | 定期报告 | 2021-06-03 |
| 2021-05-14 | 2614.92 | 未披露 | 定期报告 | 2021-05-14 |
| 2021-04-28 | 2617.09 | 未披露 | 定期报告 | 2021-04-27 |
| 2021-05-14 | 2578.20 | 0.35 |
更多>>
From Janauary 1, 2021 To March 31, 2021
Stock compensation
Cashless exercise of stock options
Exercise of stock options
Sale of stock in private placement, net
|
2021-03-31 |
| 2021-03-30 | 2590.68 | 未披露 | 定期报告 | 2021-03-30 |
| 2021-03-30 | 2333.06 | 0.35 |
更多>>
from December 31, 2019 to December 31, 2020
Stock issued for services
Exercise of warrants
Exercise of stock options
Cashless exercise of warrants
Cashless exercise of stock options
Sale of common stock
Sale of stock in private placement, net
Shares issued for share liability (proceeds received in prior period)
Common stock issued for debt exchange agreement
Common stock issued for conversion of debt
Rounding due to reverse split
|
2020-12-31 |
| 2020-12-29 | 2318.08 | 未披露 | 定期报告 | 2020-12-28 |
| 2020-12-07 | 2099.24 | 未披露 | 定期报告 | 2020-12-11 |
From December 31, 2024 to December 31, 2025
Stock compensation expense
Stock issued for debt conversion
Stock issued for asset acquisition
Exercise of stock options
Exercise of warrants
Sale of common stock under ATM, net
Cashless exercise of stock options
Cashless exercise of warrants
From June 30, 2025 to September 30, 2025
Stock compensation expense
Cashless exercise of stock options
Exercise of stock options
Exercise of warrants
Sale of common stock under ATM, net
From March 31, 2025 to June 30, 2025
Stock compensation expense
Cashless exercise of stock options
Cashless exercise of warrants
Stock issued for debt conversion
Stock issued for asset acquisition
From January 1, 2025 to March 31, 2025
Cashless exercise of options
Stock compensation expense
From December 31, 2023 to December 31, 2024
Stock compensation expense
Stock issued for noncontingent consideration payment
Exercise of stock options
Cashless exercise of warrants
Cashless exercise of stock options
From June 30, 2024 to September 30, 2024
Stock compensation expense
From March 31, 2024 to June 30, 2024
Stock compensation expense
Exercise of stock options
Cashless exercise of stock options
Cashless exercise of warrants
From January 1, 2024 to March 31, 2024
Stock compensation expense
Cashless exercise of options
Stock issued for noncontingent consideration payment
Exercise of stock options
Cashless exercise of warrants
From December 31,2022 to December 31,2023
Stock compensation expense
Cashless exercise of stock options
Cashless exercise of warrants
Exercise of stock options
Stock issued for noncontingent consideration payments
Stock issued for legal settlement
Sale of common stock under ATM, net
Stock issued for debt conversion
Common stock issued to Medifast
Series B Preferred Stock conversion
From June 30, 2023 to September 30, 2023
Sale of common stock under ATM, net
Series B Preferred Stock conversion
Cashless exercise of stock options
Stock compensation expense
Stock issued for noncontingent consideration payment
Stock issued for legal settlement
From January 1, 2023 to March 31, 2023
Stock compensation expense
Stock issued for noncontingent consideration payment
From December 31, 2021 to December 31, 2022
Stock compensation expense
Exercise of stock options
Exercise of warrants
Cashless exercise of stock options
Stock issued for legal settlement
From June 30, 2022 to September 30, 2022
Stock compensation expense
Stock issued for legal settlement
Cashless exercise of stock options
From March 31, 2022 to June 30, 2022
Exercise of stock options
From January 1, 2022 to March 31, 2022
Stock compensation
Cashless exercise of stock options
Exercise of warrants
From December 31, 2020 to December 31, 2021
Stock issued for services
Exercise of stock options
Exercise of warrants
Cashless exercise of stock options
Warrants issued for debt instruments
Sale of common stock in private placement, net
Sale of common stock under ATM, net
Sale of Series A Preferred Stock
Sale of common stock
1.Common stock offered 3,333,334 shares.
2.The number of shares of common stock outstanding before and after this offering is based on 26,759,935 shares of common stock outstanding as of September 24, 2021.
From June 30, 2021 to September 30, 2021
Stock issued for services
Exercise of stock options
Exercise of warrants
Sale of common stock under ATM
From March 31, 2021 to June 30, 2021
Stock issued for services
Exercise of stock options
Cashless exercise of stock options
Exercise of warrants
From Janauary 1, 2021 To March 31, 2021
Stock compensation
Cashless exercise of stock options
Exercise of stock options
Sale of stock in private placement, net
from December 31, 2019 to December 31, 2020
Stock issued for services
Exercise of warrants
Exercise of stock options
Cashless exercise of warrants
Cashless exercise of stock options
Sale of common stock
Sale of stock in private placement, net
Shares issued for share liability (proceeds received in prior period)
Common stock issued for debt exchange agreement
Common stock issued for conversion of debt
Rounding due to reverse split